CoChat

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

Open access
Bougnaud, Sébastien, Golebiewska, Anna, Oudin, Anaïs, Keunen, Olivier, Harter, Patrick N., Mäder, Lisa, Azuaje, Francisco, Fritah, Sabrina, Stieber, Daniel, Kaoma, Tony, Vallar, Laurent, Brons, Nicolaas H.C., Daubon, Thomas, Miletic, Hrvoje, Sundstrøm, Terje, Herold-Mende, Christel, Mittelbronn, Michel, Bjerkvig, Rolf, Niclou, Simone P. · 2016 · Oncotarget
Cited by 87

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Sébastien Bougnaud 1 , Anna Golebiewska 1 , Anaïs Oudin 1 , Olivier Keunen 1 , Patrick N. Harter 2 , Lisa Mäder 2 , Francisco Azuaje 1 , Sabrina Fritah 1 , Daniel Stieber 1 , Tony Kaoma 3 , Laurent Vallar 3 , Nicolaas H.C. Brons 4 , Thomas Daubon 5,7 , Hrvoje Miletic 7,8,9 , Terje Sundstrøm 8,10,11 , Christel Herold-Mende 6 , Michel Mittelbronn 4 , Rolf Bjerkvig 1,7,8 and Simone P. Niclou 1,8 1 NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.) Luxembourg, Luxembourg 2 Edinger-Institute (Neurological Institute), Goethe University, Frankfurt am Main, Germany 3 Genomics and Proteomics Research Unit, Department of Oncology, Luxembourg Institute of Health (L.I.H.) Luxembourg, Luxembourg 4 Core Facility Flow Cytometry, Department of Immunology, Luxembourg Institute of Health (L.I.H.) Luxembourg, Luxembourg 5 U1029 INSERM, Angiogenesis and Cancer Microenvironment Laboratory, University of Bordeaux, Talence, France 6 Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany 7 NORLUX Neuro-Oncology, Department of Biomedicine, University of Bergen, Norway 8 K.G. Jebsen Brain Tumour Research Centre, Department of Biomedicine, University of Bergen, Bergen, Norway 9 Department of Pathology, Haukeland University Hospital, Bergen, Norway 10 Department of Clinical Medicine K1, University of Bergen, Bergen, Norway 11 Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway Correspondence to: Simone P. Niclou, email: // Keywords : glioblastoma, patient-derived xenograft, tumour microenvironment, endothelial cells, angiogenesis Received : September 30, 2015 Accepted : January 29, 2016 Published : March 25, 2016 Abstract The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we show that patient-derived glioblastoma xenografts generated in the mouse brain from organotypic spheroids reproducibly give rise to three different histological phenotypes: (i) a highly invasive phenotype with an apparent normal brain vasculature, (ii) a highly angiogenic phenotype displaying microvascular proliferation and necrosis and (iii) an intermediate phenotype combining features of invasion and vessel abnormalities. These phenotypic differences were visible during early phases of tumour development suggesting an early instructive role of tumour cells on the brain parenchyma. Conversely, we found that tumour-instructed stromal cells differentially influenced tumour cell proliferation and migration in vitro, indicating a reciprocal crosstalk between neoplastic and non-neoplastic cells. We did not detect any transdifferentiation of tumour cells into endothelial cells. Cell type-specific transcriptomic analysis of tumour and endothelial cells revealed a strong phenotype-specific molecular conversion between the two cell types, suggesting co-evolution of tumour and endothelial cells. Integrative bioinformatic analysis confirmed the reciprocal crosstalk between tumour and microenvironment and suggested a key role for TGFβ1 and extracellular matrix proteins as major interaction modules that shape glioblastoma progression. These data provide novel insight into tumour-host interactions and identify novel stroma-specific targets that may play a role in combinatorial treatment strategies against glioblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7454

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Bougnaud, S., Golebiewska, A., Oudin, A., Keunen, O., Harter, P. N., Mäder, L., Azuaje, F., Fritah, S., Stieber, D., Kaoma, T., Vallar, L., Brons, N. H. C., Daubon, T., Miletic, H., Sundstrøm, T., Herold-Mende, C., Mittelbronn, M., Bjerkvig, R., & Niclou, S. P.
Venue
Oncotarget
Published
2016-03-25
Volume
7
Issue
22
Pages
31955-31971
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2328560921
Cited by
87
References
7
FWCI
4.95
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.